LAVAL, Quebec, Jan. 30, 2017 /PRNewswire/ -- Valeant
Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX)
("Valeant" or the "Company") today announced that it plans to hold
a conference call and live webcast on Tuesday, February 28, 2017 at 8:00 a.m. ET. The Company will discuss fourth
quarter and full year 2016 financial results, and announce 2017
guidance during the presentation. Related materials will be
made available on the investor relations portion of the corporate
website before the start of the conference call.
Conference Call Details
Date
|
Tuesday, February 28,
2017
|
Time
|
8:00 a.m.
ET
|
Webcast
|
http://ir.valeant.com/events-and-presentations
|
Participant Event
Dial-in
|
(877) 876-8393 (North
America)
|
|
(443) 961-0178
(International)
|
Participant
Passcode
|
63999208
|
Replay
Dial-in
|
(855) 859-2056 (North
America)
|
|
(404) 537-3406
(International)
|
Replay
Passcode
|
63999208 (replay
available until 03/31/2017)
|
About Valeant
Valeant Pharmaceuticals International,
Inc. (NYSE/TSX:VRX) is a multinational specialty pharmaceutical
company that develops, manufactures and markets a broad range of
pharmaceutical products primarily in the areas of dermatology,
gastrointestinal disorders, eye health, neurology and branded
generics. More information about Valeant can be found at
www.valeant.com.
Contact Information:
Elif
McDonald
elif.mcdonald@valeant.com
514-856-3855
877-281-6642 (toll free)
Media:
Renée Soto or
Chris
Kittredge/Jared Levy
Sard Verbinnen & Co.
212-687-8080
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/valeant-to-hold-conference-call-to-present-fourth-quarter-and-full-year-2016-results-and-announce-2017-guidance-300398963.html
SOURCE Valeant Pharmaceuticals International, Inc.